The agreement establishes a framework for joint action against Bundibugyo virus disease, viral haemorrhagic fevers, cholera and other infectious disease threats that could spread across the border.
Since South Sudan introduced SMC in 2022, the programme has helped protect children aged three to 59 months from malaria during peak transmission periods.
The initiative focused on border communities, refugee camps, and other vulnerable areas where frequent cross-border movement increases the risk of disease transmission.